NCT07424703

Brief Summary

This trial aims to investigate whether morning bright light therapy can reduce the progression rate of idiopathic scoliosis in children and potentially prevent its de novo development.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
27mo left

Started Sep 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress26%
Sep 2025Sep 2028

Study Start

First participant enrolled

September 1, 2025

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

February 14, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 20, 2026

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2028

Last Updated

May 19, 2026

Status Verified

May 1, 2026

Enrollment Period

3 years

First QC Date

February 14, 2026

Last Update Submit

May 14, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Scoliosis Curve Angle

    A long standard standing whole spine radiograph will be used for measuring curve size in terms of Cobb angle according to the standard Cobb method

    Routine follow-up visits will be scheduled 6 months apart up to 24 months

  • Angle of Trunk Rotation

    In addition to spinal X-rays, a Scoliometer can also help monitor curve progression. The Scoliometer is an inclinometer that measures the asymmetries between the sides of the trunk by measuring axial rotation in degrees. Numerous studies have found a high correlation between trunk axial rotation (ATR) values and the Cobb angles.

    Routine follow-up visits will be scheduled 6 months apart up to 24 months

Secondary Outcomes (4)

  • Scoliosis Research Society-22 (SRS-22) questionnaire

    Routine follow-up visits will be scheduled 6 months apart up to 24 months

  • Self-Report Circadian rhythm Measurements

    At baseline and months 6

  • Objective Circadian Measurements: Dim-light melatonin onset (DLMO)

    At baseline and months 6

  • Gene Expression of Circadian Biomarkers

    At baseline and months 6

Study Arms (2)

Bright Light Therapy plus Sleep Hygiene Education

EXPERIMENTAL

Participants will receive: (1) a portable light therapy device for morning use (15-30 minutes each weekday, upon waking) for 6 months; and (2) a one-time, standardized sleep hygiene education session at baseline, including written materials. Regular telephone follow-ups will be conducted to monitor and encourage adherence.

Device: Bright Light Therapy

Sleep Hygiene Education Only

ACTIVE COMPARATOR

Participants will receive an identical one-time, standardized sleep hygiene education session and materials as provided to the experimental group. No light therapy device will be provided.

Behavioral: Sleep Hygiene Education

Interventions

Bright Light Therapy plus Sleep Hygiene Education. Use of a portable light therapy device emitting narrow-band blue light (peak wavelength 480 nm) at an intensity of 400 lux, for 15-30 minutes each weekday morning immediately upon waking, for 6 consecutive months.

Bright Light Therapy plus Sleep Hygiene Education

Sleep Hygiene Education Only

Sleep Hygiene Education Only

Eligibility Criteria

Age10 Years - 15 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age between 10 and 15 years.
  • Classified as evening chronotype based on the reduced Horne-Östberg Morningness-Eveningness Questionnaire (rMEQ), defined as a score \< 12.
  • Has undergone radiographic evaluation (standing full-spine X-ray) for idiopathic scoliosis at the initial clinic visit.
  • Skeletally immature (Risser sign 0-3) with a major Cobb angle \< 40 degrees at baseline.
  • Written informed consent/assent provided by the participant and legal guardian.
  • Willing and able to comply with the study protocol, including device use and scheduled follow-ups.

You may not qualify if:

  • Plans to relocate outside the study area within the next 24 months.
  • Use of medications that may interfere with circadian rhythm within the past 3 months (e.g., lithium, exogenous melatonin, melatonergic antidepressants).
  • Trans-meridian travel across at least two time zones within the past 3 months or anticipated during the study period.
  • Presence of any eye disease (e.g., glaucoma, retinal disease, macular degeneration) that could be exacerbated by or interfere with light therapy.
  • Clinically diagnosed sleep disorder (e.g., narcolepsy, restless legs syndrome) or prominent medical condition known to interfere with sleep continuity and quality (e.g., moderate-to-severe eczema).
  • Severe chronic health conditions that could confound study outcomes, including but not limited to:
  • Known syndromic, neuromuscular, or congenital musculoskeletal causes of scoliosis.
  • History of spine surgery or significant spinal trauma.
  • Spinal tumor.
  • Leg length discrepancy \> 20 mm.
  • Other severe chronic diseases (e.g., poorly controlled diabetes, chronic liver or renal disease, malabsorption syndromes).
  • Severe obesity (body mass index z-score ≥ 3).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Second Affiliated Hospital of Wenzhou Medical University

Zhejiang, Zhejiang, 325000, China

RECRUITING

MeSH Terms

Interventions

Ultraviolet Therapy

Intervention Hierarchy (Ancestors)

PhototherapyTherapeutics

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The radiologists measuring Cobb angles will be blinded to treatment allocation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D., Chief physician, Doctorial superviso

Study Record Dates

First Submitted

February 14, 2026

First Posted

February 20, 2026

Study Start

September 1, 2025

Primary Completion (Estimated)

September 1, 2028

Study Completion (Estimated)

September 1, 2028

Last Updated

May 19, 2026

Record last verified: 2026-05

Locations